| Literature DB >> 32072744 |
Gloria M Ursino1, Ying Fu2, Denny L Cottle1, Nigora Mukhamedova2, Lynelle K Jones1, Hann Low2, Ming Shen Tham1, Wan Jun Gan3, Natalie A Mellett2, Partha P Das1, Jacquelyn M Weir2, Michael Ditiatkovski2, Stacey Fynch4, Peter Thorn3, Helen E Thomas4, Peter J Meikle2, Helena C Parkington5, Ian M Smyth1, Dmitri Sviridov2.
Abstract
Dysregulation of lipid homeostasis is intimately associated with defects in insulin secretion, a key feature of type 2 diabetes. Here, we explore the role of the putative lipid transporter ABCA12 in regulating insulin secretion from β-cells. Mice with β-cell-specific deletion of Abca12 display impaired glucose-stimulated insulin secretion and eventual islet inflammation and β-cell death. ABCA12's action in the pancreas is independent of changes in the abundance of two other cholesterol transporters, ABCA1 and ABCG1, or of changes in cellular cholesterol or ceramide content. Instead, loss of ABCA12 results in defects in the genesis and fusion of insulin secretory granules and increases in the abundance of lipid rafts at the cell membrane. These changes are associated with dysregulation of the small GTPase CDC42 and with decreased actin polymerisation. Our findings establish a new, pleiotropic role for ABCA12 in regulating pancreatic lipid homeostasis and insulin secretion.Entities:
Keywords: ABCA12; cholesterol homeostasis; insulin secretion; lipid rafts; type 2 diabetes
Mesh:
Substances:
Year: 2020 PMID: 32072744 PMCID: PMC7054684 DOI: 10.15252/embr.201948692
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807